MicroRNA-638 inhibits cell growth and tubule formation by suppressing VEGFA expression in human Ewing Sarcoma cells.

about

MicroRNA-638 inhibits cell growth and tubule formation by suppressing VEGFA expression in human Ewing Sarcoma cells.

Item

http://www.wikidata.org/entity/Q47269424

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

MicroRNA-638 inhibits cell gro ...... in human Ewing Sarcoma cells.

@en

MicroRNA-638 inhibits cell gro ...... in human Ewing Sarcoma cells.

@nl

type

Item

label

MicroRNA-638 inhibits cell gro ...... in human Ewing Sarcoma cells.

@en

MicroRNA-638 inhibits cell gro ...... in human Ewing Sarcoma cells.

@nl

prefLabel

MicroRNA-638 inhibits cell gro ...... in human Ewing Sarcoma cells.

@en

MicroRNA-638 inhibits cell gro ...... in human Ewing Sarcoma cells.

@nl

P1476

MicroRNA-638 inhibits cell gro ...... in human Ewing Sarcoma cells.

@en

P2093

Bo Li

http://www.w3.org/2001/XMLSchema#string

Gaohai Shao

http://www.w3.org/2001/XMLSchema#string

Jiajun Chen

http://www.w3.org/2001/XMLSchema#string

Qianren Xiao

http://www.w3.org/2001/XMLSchema#string

Tengyu Wang

http://www.w3.org/2001/XMLSchema#string

Xin Zhou

http://www.w3.org/2001/XMLSchema#string

Yu Yu

http://www.w3.org/2001/XMLSchema#string

Yunyun Li

http://www.w3.org/2001/XMLSchema#string

Zhongzu Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Exploring the surfaceome of Ewing sarcoma identifies a new and unique therapeutic target

Global microRNA depletion suppresses tumor angiogenesis.

Loss of miR-638 in vitro promotes cell invasion and a mesenchymal-like transition by influencing SOX2 expression in colorectal carcinoma cells.

MicroRNA-638 inhibits cell proliferation, invasion and regulates cell cycle by targeting tetraspanin 1 in human colorectal carcinoma.

Tumor Vessel Development and Expansion in Ewing's Sarcoma: A Review of the Vasculogenesis Process and Clinical Trials with Vascular-Targeting Agents.

miR-638 regulates differentiation and proliferation in leukemic cells by targeting cyclin-dependent kinase 2

miR-638 is a new biomarker for outcome prediction of non-small cell lung cancer patients receiving chemotherapy.

Getting to the root of miRNA-mediated gene silencing.

Ewing sarcoma: historical perspectives, current state-of-the-art, and opportunities for targeted therapy in the future.

Downregulation of miRNA-638 promotes angiogenesis and growth of hepatocellular carcinoma by targeting VEGF.

P31

scholarly article

P356

10.1042/BSR20171017

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29263143

http://www.w3.org/2001/XMLSchema#string

P921

microRNA

P932

5773810

http://www.w3.org/2001/XMLSchema#string